Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
28,234,434
-
Total 13F shares
-
3,102,980
-
Share change
-
+855,417
-
Total reported value
-
$65,594,982
-
Price per share
-
$21.14
-
Number of holders
-
50
-
Value change
-
+$19,961,387
-
Number of buys
-
37
-
Number of sells
-
12
Institutional Holders of ClearPoint Neuro, Inc. - Common Stock, $0.01 par value (CLPT) as of Q1 2021
As of 31 Mar 2021,
ClearPoint Neuro, Inc. - Common Stock, $0.01 par value (CLPT) was held by
50 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,102,980 shares.
The largest 10 holders included
VANGUARD GROUP INC, Parian Global Management LP, BlackRock Inc., MILLENNIUM MANAGEMENT LLC, Kepos Capital LP, GEODE CAPITAL MANAGEMENT, LLC, PARSONS CAPITAL MANAGEMENT INC/RI, SUSQUEHANNA INTERNATIONAL GROUP, LLP, CONWAY CAPITAL MANAGEMENT, INC., and RENAISSANCE TECHNOLOGIES LLC.
This page lists
50
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.